We recently compiled a list of the Why These 24 Stocks Are Skyrocketing. In this article, we are going to take a look at where Aligos Therapeutics, Inc. (NASDAQ:ALGS) stands against the other stocks.

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Shares of Aligos Therapeutics, Inc. (ALGS) have been struggling lately and have lost 8.1% over the past two weeks. However, a hammer chart pattern was formed in its last trading session, which could ...

(RTTNews) - Aligos Therapeutics, Inc. (ALGS) has reported recent business progress and outlined continued advancement across its pipeline of drug candidates purpose-built for liver and viral diseases.